PREVALENCE, ANTIMICROBIAL RESISTANCE PROFILES OF CLINICAL AND SUBCLINICAL MASTITIS IN LACTATING COW WITH ASSESSMENT OF TREATMENT TRIAL
DOI:
https://doi.org/10.26873/SVR-1618-2022Abstract
This work investigated the prevalence of bovine mastitis in a dairy farm, Ismalia governrate, Egypt with phynotypic and genotypic clarification of the causative bacteria and their antimicrobial susceptibility. Also a treatment trial with a combination of Cafalexin, Kanamycin was evaluated. The total prevalence of mastitis was 31.82% (119/374) at cow level and 17.01% (247/1452) at quarter level. 261 isolates were detected. (74.33%) belong to staphylococcus spp and (25.67%) to streptococcus spp. as major microorganisms (CNS (42.53%) s.aurus (31.80%) s. uberis (12.26%), s. agalactia (8.81%) and s. dysagalactia(4.59%). The isolates were tested against 15 antimicrobial agents and the highest percentage of resistant bacteria was for AMC, P, C and E. while the lowest rate was for CN, CIP, CL and K. Molecular Characterization of isolated pathogens and antimicrobial resistance genes was performed by PCR on 15 isolates. blaTEM-1 Was the most frequently detected gen followed by aadA1, dfrA1, cmlA, sul1, and tetA. 110 infected udder quarters were enrolled for 21 days to evaluate the treatment with Terrexine LC intramammary suspension 10g on six occasions at 12 h intervals and gentamycin intramuscular injection (1cm/20kg Bw for 3-5 days in cows with systemic reaction. A high significant reduction was recorded for the log10 SSC, log10 TBC and the level of LDH in milk after treatment compared their level before treatment (P-value <0.0001***). The milk season for cows, degree of mastitis or type of microorganism isolated before treatment have no effect on the recovery rate P-value ˃0.05. In conclusion, the emergence of multidrug-resistant strains is greatly increased so antibiotic usage must be Restricted. PCR can help in the rapid detection of the resistant strains. Treatment of mastitis with combination of antimicrobial may reduce drug resistance. Bovine mastitis still needs updated knowledge on the causative microbes and their antibiotic resistance patterns for optimal control and treatment.
References
GAIN. Egypt Livestock and Products Annual 2018 [Available from: https://apps.fas.usda.gov/newgainapi/api/report/downloadreportbyfilename?filename=Livestock%20and%20%E2%80%8EProducts%20AnnualCairo_Egypt_9-19-2018.pdf%E2%80%8E.
Miller G, Bartlett P, Lance S, Anderson J, Heider LE. Costs of clinical mastitis and mastitis prevention in dairy herds. J Am Vet Med Assoc. 1993;202:1230-1236.
Gomes F, Henriques M. Control of bovine mastitis: old and recent therapeutic approaches. Curr. Microbiol. 2016;72:377-382.
Valeeva N, Lam T, Hogeveen H. Motivation of dairy farmers to improve mastitis management. J. Dairy Sci. 2007;90:4466-4477.
Ruegg PL. What is success? A narrative review of research evaluating outcomes of antibiotics used for treatment of clinical mastitis. Front. vet. sci. 2021;8:639-641.
Hillerton J, Berry E. A review. Treating mastitis in the cow-a tradition or an archaism. J. app microbiol. 2005;98:1250-1255.
El-Jakee J, Atta NS, Samy A, Bakry M, Elgabry E, Kandil MM, et al. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from bovine and human sources in Egypt. Glob Vet. 2011;7:581-586.
Ameen F, Reda SA, El-Shatoury SA, Riad EM, Enany ME, Alarfaj AA. Prevalence of antibiotic resistant mastitis pathogens in dairy cows in Egypt and potential biological control agents produced from plant endophytic actinobacteria. Saudi J. Biol. Sci. 2019;26:1492-1498.
Pillai SK, Moellering R, Eliopoulos GM. Antimicrobial combinations. Antibiotics in laboratory medicine. 2005;5:365-440.
Davis BD. Bactericidal synergism between β-lactams and aminoglycosides: mechanism and possible therapeutic implications. Rev. Infect. Dis. 1982;4:237-245.
Boman HG, Faye I, Gudmundsson GH, Lee J-Y, Lidholm D-A. Cell-free immunity in Cecropia. EJB Reviews 1991. 1991:189-197.
Ganière J-P, Denuault L. Synergistic interactions between cefalexin and kanamycin in Mueller–Hinton broth medium and in milk. J. app microbiol. 2009;107:117-125.
Sérieys F, Raguet Y, Goby L, Schmidt H, Friton G. Comparative efficacy of local and systemic antibiotic treatment in lactating cows with clinical mastitis. J. Dairy Sci. 2005;88:93-99.
Suojala L, Simojoki H, Mustonen K, Kaartinen L, Pyörälä S. Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis. J. Dairy Sci. 2010;93:1960-1969.
Chagunda MG, Larsen T, Bjerring M, Ingvartsen KL. L-lactate dehydrogenase and N-acetyl-β-D-glucosaminidase activities in bovine milk as indicators of non-specific mastitis. J. Dairy Res. 2006;73:431-440.
Nyman A-K, Waller KP, Bennedsgaard T, Larsen T, Emanuelson U. Associations of udder-health indicators with cow factors and with intramammary infection in dairy cows. J. Dairy Sci. 2014;97:5459-5473.
Roberson J, Warnick L, Moore G. Mild to moderate clinical mastitis: Efficacy of intramammary amoxicillin, frequent milk-out, a combined intramammary amoxicillin, and frequent milk-out treatment versus no treatment. J. Dairy Sci. 2004;87:583-592.
Clements AC, Taylor DJ, Fitzpatrick JL. Evaluation of diagnostic procedures for subclinical mastitis in meat-producing sheep. J. Dairy Res. 2003;70:139-148.
Barrow G, Felthman R. Cowan and Steel's Manual for identification of Medical Bacteria, 3rd edn., Cambridge University. London Press, Cambridge. UK; 1993.
Finegold S. Enterobacteriaceae and non fermentative gram negative bacilli In Bailey and Scott's diagnostic microbiology Finegold, SM and Martin WJ (eds). CV Mosby Company, St-Louis. Toronto London. 1982:199-239.
CLSI. Performance standards for antimicrobial susceptibility testing: twenty-second information supplement M100-S22. Wayne, Pa.: CLSI.2012.
Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol. 2006;55:1619-1629.
Papich MG. Antimicrobials, susceptibility testing, and minimum inhibitory concentrations (MIC) in veterinary infection treatment. Veterinary Clinics: Small Animal Practice. 2013;43:1079-1089.
Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://wwwR-project.org/. 2013.
Seegers H, Fourichon C, Beaudeau F. Production effects related to mastitis and mastitis economics in dairy cattle herds. Veterinary research. 2003;34:475-491.
Elbably M, Emeash H, Asmaa N. Risk factors associated with mastitis occurrence in dairy herds in Benisuef, Egypt. World's Vet. J. 2013;3:5-10.
Algammal AM, Enany ME, El-Tarabili RM, Ghobashy MO, Helmy YA. Prevalence, antimicrobial resistance profiles, virulence and enterotoxins-determinant genes of MRSA isolated from subclinical bovine mastitis in Egypt. Pathogens. 2020;9:362.
Mbindyo CM, Gitao GC, Plummer PJ, Kulohoma BW, Mulei CM, Bett R. Antimicrobial resistance profiles and genes of Staphylococci isolated from mastitic cow’s milk in Kenya. Antibiotics. 2021;10:772.
Ali A, Ganie S, Mir M, Ahmad S, Bhat R, Mir B. Risk factors associated with subclinical mastitis in dairy cows reared in district Ganderbal, Jammu and Kashmir. Journal of Veterinary and Animal Sciences (JVAS). 2021.
Piepers S, De Vliegher S, de Kruif A, Opsomer G, Barkema H. Impact of intramammary infections in dairy heifers on future udder health, milk production, and culling. Vet microbiol. 2009;134:113-120.
Oliveira C, Hogeveen H, Botelho A, Maia P, Coelho S, Haddad J. Cow-specific risk factors for clinical mastitis in Brazilian dairy cattle. Prev. Vet. Med. 2015;121:297-305.
Condas LA, De Buck J, Nobrega DB, Carson DA, Roy J-P, Keefe GP, et al. Distribution of non-aureus staphylococci species in udder quarters with low and high somatic cell count, and clinical mastitis. J. Dairy Sci. 2017;100:5613-5627.
León-Galván M, Barboza-Corona JE, Lechuga-Arana AA, Valencia-Posadas M, Aguayo DD, Cedillo-Pelaez C, et al. Molecular detection and sensitivity to antibiotics and bacteriocins of pathogens isolated from bovine mastitis in family dairy herds of central Mexico. Biomed Res. Int. 2015;2015.
Pitkälä A, Haveri M, Pyörälä S, Myllys V, Honkanen-Buzalski T. Bovine mastitis in Finland 2001—prevalence, distribution of bacteria, and antimicrobial resistance. J. dairy sci. 2004;87(8):2433-2441.
Vakkamäki J, Taponen S, Heikkilä A-M, Pyörälä S. Bacteriological etiology and treatment of mastitis in Finnish dairy herds. Acta Vet. Scand. 2017;59:1-9.
Zeryehun T, Abera G. Prevalence and bacterial isolates of mastitis in dairy farms in selected districts of Eastern Harrarghe zone, Eastern Ethiopia. J. vet med. 2017;2017.
Sayed S, MANSY F, El-Berbawy S. Bacteriological studies on sub-clinical mastitis in cows and buffaloes with trails for its treatment. Assiut Vet. Med. J. 2011;57:1-17.
Sayed S, Abd El-Hafeez M. Bacteriological studies on pathogens causing sub-clinical mastitis in Holstein-Friesian dairy cows in Assiut Governorate. Assiut Vet. Med. J. 2009;55:1-13.
Verbeke J, Piepers S, Supré K, De Vliegher S. Pathogen-specific incidence rate of clinical mastitis in Flemish dairy herds, severity, and association with herd hygiene. J. dairy sci. 2014;97:6926-6934.
Mustafa EL-Kholy A, Mohamed Hassan G, Maarouf ALI Zeinhom M, Adel Ahmed Mohamed El-Klawy M. Detection of subclinical mastitis in a dairy farm in Beni-Suef city, Egypt. Assiut Vet. Med. J. 2018;64:18-24.
Ndahetuye JB, Persson Y, Nyman A-K, Tukei M, Ongol MP, Båge R. Aetiology and prevalence of subclinical mastitis in dairy herds in peri-urban areas of Kigali in Rwanda. Trop. Anim. Health Prod. 2019;51:2037-2044.
Taponen S, Simojoki H, Haveri M, Larsen HD, Pyörälä S. Clinical characteristics and persistence of bovine mastitis caused by different species of coagulase-negative staphylococci identified with API or AFLP. Vet microbiol. 2006;115(1-3):199-207.
Pyörälä S, Taponen S. Coagulase-negative staphylococci—Emerging mastitis pathogens. Vet microbiol. 2009;134:3-8.
Tenhagen B-A, Köster G, Wallmann J, Heuwieser W. Prevalence of mastitis pathogens and their resistance against antimicrobial agents in dairy cows in Brandenburg, Germany. J. Dairy Sci. 2006;89:2542-2551.
El-Jakee JK, Aref NE, Gomaa A, El-Hariri MD, Galal HM, Omar SA, et al. Emerging of coagulase negative staphylococci as a cause of mastitis in dairy animals: An environmental hazard. Int. J. Vet. Sci. Med. 2013;1:74-78.
Timms L, Schultz L. Dynamics and significance of coagulase-negative staphylococcal intramammary infections. J. Dairy Sci. 1987;70:2648-2657.
De Vliegher S, Barkema H, Stryhn H, Opsomer G, de Kruif A. Impact of early lactation somatic cell count in heifers on milk yield over the first lactation. J. Dairy Sci. 2005;88:938-947.
Piessens V, Van Coillie E, Verbist B, Supré K, Braem G, Van Nuffel A, et al. Distribution of coagulase-negative Staphylococcus species from milk and environment of dairy cows differs between herds. J. Dairy Sci. 2011;94:2933-2944.
Thorberg B-M, Danielsson-Tham M-L, Emanuelson U, Waller KP. Bovine subclinical mastitis caused by different types of coagulase-negative staphylococci. J. Dairy Sci. 2009;92:4962-4970.
Mousa W, Zaghawa A, Nayel M. Studies on clinical and subclinical mastitis in Menoufia Governate with application of PCR for diagnosis. Journal of Current Veterinary Research (JCVR). 2015;9:78-84.
Mostafa AE, Hammad A. Phenotypic and Molecular Characterization of Methicillin-Resistant Staphylococcus Aureus Isolated from Bovine Mastitis in Egypt. Journal of Current Veterinary Research (JCVR). 2021;3:23-29.
El-Ashker M, Gwida M, Tomaso H, Monecke S, Ehricht R, El-Gohary F, et al. Staphylococci in cattle and buffaloes with mastitis in Dakahlia Governorate, Egypt. J. Dairy Sci. 2015;98:7450-7459.
Abdel-Tawab AA, El-Hofy FI, Maarouf AA, Abbas SA. Molecular detection of some virulence genes of S. aureus isolated from mastitic Cows by PCR. Benha Veterinary Medical Journal (BVMJ). 2016;30:238-245.
El Faramaway RT, Abdeen EE, Ashraf A-TA, Mousa WS. Antibiogram Profile and Molecular Characterization of coa and spa Genes Of Methicillin Resistant Staphylococcus aureus (MRSA) from Clinical Mastitis. Alex. J. Vet. Sci. 2019;61.
Scherrer D, Corti S, Muehlherr J, Zweifel C, Stephan R. Phenotypic and genotypic characteristics of Staphylococcus aureus isolates from raw bulk-tank milk samples of goats and sheep. Vet Microbiol. 2004;101:101-107.
Duse A, Persson-Waller K, Pedersen K. Microbial aetiology, antibiotic susceptibility and pathogen-specific risk factors for udder pathogens from clinical mastitis in dairy cows. Animals. 2021;11:2113.
Hasan M, Islam M, Runa N, Uddin A, Singh S. Study on bovine sub-clinical mastitis on farm condition with special emphasis on antibiogram of the causative bacteria. Bangladesh j. vet. med. 2016;14:161-166.
Abd El-Aziz NK, Ammar AM, El Damaty HM, Abd Elkader RA, Saad HA, El-Kazzaz W, et al. Environmental Streptococcus uberis associated with clinical mastitis in dairy cows: virulence traits, antimicrobial and biocide resistance, and epidemiological typing. Animals. 2021;11:1849.
Harmon R. Mastitis and milk quality. Milk quality: Springer; 1995. p. 25-39.
Abd El KAE-H, Arafa AA, Fouad EA, Younes AM, Almuzaini AM, Abdou AM. Isolation, identification and virulence determinants of Streptococcus agalactiae from bovine subclinical mastitis in Egypt. J. Infect. Dev. Ctries. 2021;15:1133-1138.
Yang W-T, Ke C-Y, Wu W-T, Lee R-P, Tseng Y-H. Effective treatment of bovine mastitis with intramammary infusion of Angelica dahurica and Rheum officinale extracts. Evid. Based Complementary Altern. Med. 2019;2019.
Yang C-H, Lee S-Y, Pan H-Y, Su P-W, Chuang L-Y. Prevalence and molecular characterization of plasmidmediated beta-lactamase genes among nosocomial Staphylococcus aureus isolated in Taiwan. TROP J PHARM RES. 2017;16:155-160.
Pinzón-Sánchez C, Ruegg P. Risk factors associated with short-term post-treatment outcomes of clinical mastitis. J. Dairy Sci. 2011;94(7):3397-410.
McDougall S. Intramammary treatment of clinical mastitis of dairy cows with a combination of lincomycin and neomycin, or penicillin and dihydrostreptomycin. N Z Vet J. 2003;51:111-116.
Krabbenhoft K, Adams AP, Schipper I. Antibiotic sensitivities of organisms isolated from mastitic and nonmastitic mammary secretions. Appl. Microbiol. 1965;13:762-765.
Maneke E, Pridmore A, Goby L, Lang I. Kill rate of mastitis pathogens by a combination of cefalexin and kanamycin. J. Appl. Microbiol. 2011;110:184-190.
Franklin A, Olof H, Rantzien M, Aström G. Effect of procaine benzylpenicillin alone or in combination with dihydrostreptomycin on udder pathogens in vitro and in experimentally infected bovine udders. Am. J. Vet. Res. 1984;45:1398-1402.
Bradley A, Green M. Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations. J. Dairy Sci. 2009;92:1941-1953.
Fuenzalida M, Ruegg P. Negatively controlled, randomized clinical trial to evaluate use of intramammary ceftiofur for treatment of nonsevere culture-negative clinical mastitis. J. Dairy Sci. 2019;102:3321-3338.
Fogsgaard K, Løvendahl P, Bennedsgaard T, Østergaard S. Changes in milk yield, lactate dehydrogenase, milking frequency, and interquarter yield ratio persist for up to 8 weeks after antibiotic treatment of mastitis. J. Dairy Sci. 2015;98:7686-7698. 71. Bogin E , Ziv G, Avidar J. Enzyme-activities in normal and inflamed bovine udder tissues. Zentralblatt für Veterinärmedizin Reihe. 1976; 23: 460-466 10.1111/j.1439-0442.1976.tb01726.x
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Wafaa El-Neshwy, Abo-Zaid, A.A.,, El-Mekawey, M.F, Soliman, A.H
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
